Again same news from * today:Zelira Therapeutics Limited...

Again same news from * today:

Zelira Therapeutics Limited (ASX:ZLD) raised US$5m at an incredible 54% premium to the previous closing price to accelerate growth initiatives. The placement was placed to a US-based Family Office. The raise was priced at 6c per share with a 1:2 unlisted free attaching option exercisable at 9c per share with a two-year expiry.The capital raise also included a US$1.5m investment in Zelira Dermatology for a 3% shareholding in that company, valuing Zelira at US$50m. Zelira is now valued at a massive US$122m, which comprises US$50m from the listed entity and US$50m in Zelira Dermatology which Zelira holds 78% of interest in post-funding.